Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_417378fb52bdc7f1f45ab9af2a8bc49a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2535-131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
filingDate |
2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cc3bfae6a9c11f2dbaded87e5c8433e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e56cf7497f624a03bd59041f64f2ff0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d5964fb74c5f75e5f700771702e264 |
publicationDate |
2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2640256-C2 |
titleOfInvention |
Means and methods of predicting response to treatment of hepatitis b |
abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to a method of determining whether a patient with hepatitis b (HBV) has an increased probability of a positive outcome of hepatitis B treatment compared to the average probability in a population of patients with hepatitis B. The proposed method includes establishing whether the sample with nucleic acid of specified patient with hepatitis B, associated with positive result of G allele of SNP rs 12356193.EFFECT: invention allows you to determine whether a patient with HBV will respond to HBV therapy prior to therapy, and gives the possibility to avoid unnecessary expenditure and the emergence of side-effects and complications during treatment.9 cl, 24 dwg, 3 tbl, 4 ex |
priorityDate |
2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |